lamotrigine and blood dyscrasias

Last reviewed 01/2018

  • various blood dyscrasias have been reported associated with the use of lamotrigine world-wide

  • assessment of individual reports indicates that lamotrigine is likely to be the causative factor in the reported cases of blood dyscrasias associated with use of lamotrigine

  • routine FBC monitoring is not, at present, recommended in patients treated with lamotrigine

Check the summary of product characteristics before prescribing this drug.